APOE and Alzheimer disease: A meta-analysis showed APOE e4 genotype prevalence varies among the population diagnosed with Alzheimer’s disease (AD) by geographic region, with the highest estimates in Northern Europe and the lowest estimates in Asia and Southern Europe (Ward et al., 2012).